Cephalon’s Proposed Fentora Controls May Extend To All Rapid-Onset Opiates

Cephalon aims to launch its COVERS pilot program for the pain drug Fentora later this year and says FDA is likely to require comparable enhanced risk management for its off-patent opiate Actiq and generic versions of that product